However, the authors noted that in human tumor samples, loss of Trp53 and Kras mutations happen to be mostly mutually exclusive, unlike the animal model, but Kras and Stk11 mutations were often seen to co-exist [151]. This evidence concerns the gene KRAS and neoplasm.